MiraLAX - 11523-7341-1 - (Polyethylene Glycol 3350)

Alphabetical Index


Drug Information of MiraLAX

Product NDC: 11523-7341
Proprietary Name: MiraLAX
Non Proprietary Name: Polyethylene Glycol 3350
Active Ingredient(s): 170    mg/g & nbsp;   Polyethylene Glycol 3350
Administration Route(s): ORAL
Dosage Form(s): POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of MiraLAX

Product NDC: 11523-7341
Labeler Name: MSD Consumer Care, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: NDA022015
Marketing Category: NDA
Start Marketing Date: 20090223

Package Information of MiraLAX

Package NDC: 11523-7341-1
Package Description: 612 g in 1 BOTTLE, PLASTIC (11523-7341-1)

NDC Information of MiraLAX

NDC Code 11523-7341-1
Proprietary Name MiraLAX
Package Description 612 g in 1 BOTTLE, PLASTIC (11523-7341-1)
Product NDC 11523-7341
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Polyethylene Glycol 3350
Dosage Form Name POWDER, FOR SOLUTION
Route Name ORAL
Start Marketing Date 20090223
Marketing Category Name NDA
Labeler Name MSD Consumer Care, Inc.
Substance Name POLYETHYLENE GLYCOL 3350
Strength Number 170
Strength Unit mg/g
Pharmaceutical Classes

Complete Information of MiraLAX


General Information